8-K: Butterfly Network Director Departs for CDC Role

Butterfly Network, Inc. announces the resignation of Dr. Erica Schwartz from its Board of Directors, effective August 5, 2026, following her confirmation as Director of the Centers for Disease Control and Prevention.

Summary

• Dr. Erica Schwartz has resigned from her position as a director on Butterfly Network's Board of Directors.
• Her resignation was effective August 5, 2026, coinciding with her confirmation as Director of the Centers for Disease Control and Prevention (CDC) by the U.S. Senate.
• Dr. Schwartz's departure is not due to any disagreements with the Company regarding its operations, policies, or practices.
• Butterfly Network congratulated Dr. Schwartz on her new public service role.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, primarily a procedural update regarding a director's departure due to a significant public service appointment.

Positives

• Dr. Erica Schwartz's departure is a testament to her esteemed public service career, being appointed to a high-profile government role.
• The company expressed pride and congratulations for her well-deserved opportunity, highlighting her contributions.
• Her resignation is not linked to any internal company disputes, indicating continued stability in governance.

Negatives

• The company loses a director who served on the Board since 2021 and was considered a valued member.

Future Outlook

No specific forward-looking statements or guidance related to company performance were included in this filing.

Management Comments

• "Erica has been a valued member of our Board and someone I respect as a physician, leader, and colleague. She brings clinical credibility, a genuine commitment to public service, and a passion for what healthcare can be. She's left a lasting mark on Butterfly and we are proud to congratulate her on this well-deserved opportunity. On behalf of the Butterfly community, I thank her deeply for her contributions; we look forward to seeing the impact she'll make in this next chapter," said Joseph DeVivo, President, CEO and Chairman, Butterfly Network.

Industry Context

StockSavvy.ai notes that the departure of a board member for a high-profile public health role, while a loss of expertise, also reflects positively on the caliber of individuals associated with the company and can indirectly enhance its reputation.

Management Changes

Stakeholder Impact

• Shareholders: The departure of an experienced director may be viewed as a minor loss of governance expertise, but the reason for departure is positive and not indicative of internal issues.
• Employees: The company's leadership structure remains stable, with no indication of internal disruption.
• Public Health Community: Dr. Schwartz's appointment to the CDC is a significant event for public health, indirectly reflecting on the individuals associated with Butterfly Network.

Next Steps

• The company will continue to operate with its current Board of Directors composition.
• Butterfly Network will seek to fill the vacant board seat in due course, though no timeline is specified.

Key Dates

Keywords

Director Resignation, Board of Directors, CDC Director, Corporate Governance, Public Service Appointment